Pfizer scoops Calico exec Jeff Settleman to head big oncology R&D ops in La Jolla

Pfizer has found its new chief of oncology R&D in Calico, the Google-backed stealthy startup trying to crack the code on age-related diseases.

Jeff Settleman is stepping in as the pharma giant prepares for the retirement of Robert Abraham, whose experience in oncology research stretches back years at Wyeth.

Jeff Settleman Foghorn

Pfizer?s oncology unit has seen a bit of turnover in recent years, with a high profile departure just weeks ago when its clinical head in immuno-oncology, Dimitry Nuyten, jumped to Aduro. Charles Hugh-Jones left last August for Allergan after a 16-month stint as CMO; on